Hexima Limited Banner Image

Hexima Limited

  • Ticker HXL
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Hexima Limited Logo Image
  • 11-50 Employees
  • Based in Melbourne, Australia
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. The company was incorporated in 1997 and isMore headquartered in Melbourne, Australia.
4.8 / 5.0 (77)

Hexima Limited reports have an aggregate usefulness score of 4.8 based on 77 reviews.

Hexima Limited

Most Recent Annual Report

Hexima Limited
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Hexima Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!